Research & Development


With patent pending technology, our team of experts is leading the change in pharmaceutical research and development. Greater demand for pharmaceutical drugs demands greater innovation in the way these drugs are delivered. With our patent pending technology, Sentar is paving the way for a different approach to traditional pharmaceutical industry models of drug delivery systems. Sentars’ exclusive drug delivery system relies on sublingual technology to bypass the digestive system and bring the medication straight to the consumers circulatory system. Multiple studies have shown that sublingual delivery is superior for some medications, allowing for greater absorption rates, and a reduction in common side effects. Currently, Sentar is developing a branded line of generic drugs utilizing this innovative technology. From lifestyle to therapeutic drugs, Sentars’ unique technology is suitable for a wide variety of applications